PATENT CLAIM ANALYSIS

Application Number: 16042206
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "210000"]

Abstract:
The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Claim (Index 65):
The method of  claim 56 , wherein the agent that induces a DNA lesion is a chemotherapeutic agent.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 95.0
- Lexical Diversity: 1.29032
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14515793', '15912074', '15426150', '14205508', '14205657']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8470058628132786
- 35 USC 102 Novelty (BERT): 0.5625015267725193
- Combined Prediction Score: 0.8185554292092028
- Mean Citation Score: 415.617586
- Max Citation Score: 484.16336
- Similarity Product: 279.6240148926163

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test